Cannara Biotech Inc.
LOVE.V
TSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -69.18% | -18.00% | 27.20% | 38.18% | -60.11% |
| Total Depreciation and Amortization | -30.39% | 80.86% | -21.27% | 1.17% | -12.59% |
| Total Amortization of Deferred Charges | -6.78% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 287.40% | -27.70% | 35.20% | -13.58% | 134.64% |
| Change in Net Operating Assets | 96.14% | -165.15% | 173.75% | -2,709.07% | 242.07% |
| Cash from Operations | 176.69% | -79.16% | 654.88% | -142.01% | 82.27% |
| Capital Expenditure | -209.55% | 31.91% | -52.93% | -15.98% | -145.74% |
| Sale of Property, Plant, and Equipment | -- | 803.54% | -- | -- | -73.81% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.19% | 55.81% | -23.06% | 71.67% | -11.48% |
| Cash from Investing | -260.31% | 40.35% | -55.68% | -14.38% | -167.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.11% | 60.66% | -926.12% | 72.92% | -4.75% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 39.49% | -30.57% | 31.82% | -19.15% | 9.95% |
| Cash from Financing | 25.00% | 30.70% | -95.09% | -18.68% | 36.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,552.45% | -100.52% | 282.85% | -237.45% | 213.54% |